Gilead Sciences Inc. (GILD) Stock Quote

Detailed Quote for Gilead Sciences Inc. (GILD)

After Hours: $ 53.6817

-0.0683 (-0.13%)

Volume: 22.97 k

5:19 PM EST Feb 10, 2012

close 52 Week Information

52 Week High

February 6, 2012

Close: 56.50

52 Week Low

November 21, 2011

Close: 34.45

Today

Last Price
53.75

Change $
0.02

Change %
0.04%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
53.59

High
53.96

Low
53.42

Prev Close
53.73

Last Trade
2/10/12

Volume
7.25 m

52 Wk Hi
56.50

52 Wk Low
34.45

Market Cap
40.37 b

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
751,139,232

EPS (TTM)
3.55

PE Ratio
15.10

close Exchange Information Listed On Nasdaq Global Select (NGS) Exchange
NGS

News and Media for Gilead Sciences Inc. (GILD)

Sector News | Topic News

News for GILD

Thu, Feb 09, 2012

4:30 PM

Gilead Sciences to Present at Two Upcoming Investor Conferences - Business Wire

Wed, Feb 08, 2012

4:14 PM

Investor Uprising IU25 Index Hits New High: Up 12% in 2012 - PR Newswire

Mon, Feb 06, 2012

9:00 AM

Perception, Opportunity in Volatility - Research & Analysis on Zynga Inc and Gilead Sciences, Inc. - Marketwire

Fri, Feb 03, 2012

9:15 AM

4 Active Stocks on Traders Radar Screens for 02/03/12: GFMD, ZOLT, GILD, BAC - Marketwire

Thu, Feb 02, 2012

4:05 PM

Gilead Sciences Announces Fourth Quarter and Full Year 2011 Financial Results - Business Wire

Thu, Jan 26, 2012

4:30 PM

Gilead Sciences to Release Fourth Quarter and Year End 2011 Financial Results on Thursday, February 2, 2012 - Business Wire

Tue, Jan 24, 2012

4:05 PM

Gilead Initiates Phase 2 Clinical Trial Evaluating GS-7340, A Low-Dose Novel Prodrug of Tenofovir for the Treatment of HIV - Business Wire

Wed, Jan 18, 2012

7:15 PM

U.S. Food and Drug Administration Approves New Formulations of Viread® for Use by Children Living With HIV - Business Wire

4:40 PM

Roy D. Baynes, MD, PhD, to Join Gilead Sciences as Senior Vice President, Oncology Therapeutics - Business Wire

Tue, Jan 17, 2012

5:00 PM

Gilead Sciences Completes Acquisition of Pharmasset, Inc. - Business Wire

Thu, Jan 12, 2012

1:25 AM

Gilead Sciences Completes Tender Offer for All Outstanding Shares of Pharmasset, Inc. - Business Wire

Fri, Jan 06, 2012

4:44 PM

Gilead Sciences Announces Early Termination of Hart-Scott-Rodino Waiting Period - Business Wire

Thu, Jan 05, 2012

5:00 PM

Gilead Sciences to Present at the 30th Annual JPMorgan Healthcare Conference on Monday, January 9 - Business Wire

Fri, Dec 23, 2011

5:15 PM

U.S. FDA Accepts New Drug Application for Gilead's Once-Daily, Single-Tablet Quad HIV Regimen - Business Wire

Tue, Dec 20, 2011

4:30 PM

Gilead Files European Marketing Application for the Quad, a Once-Daily Single-Tablet Regimen for the Treatment of HIV Infection - Business Wire

Mon, Dec 19, 2011

7:30 AM

Coronado Biosciences to Begin Trading on NASDAQ Today - Marketwire

Thu, Dec 15, 2011

4:30 PM

Gilead Sciences Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Truvada® for Reducing the Risk of Acquiring HIV - Business Wire

Fri, Dec 09, 2011

8:30 AM

Gilead Announces Two-Year Data From Pivotal Phase 3 Study of Elvitegravir, an Integrase Inhibitor for HIV - Business Wire

Thu, Dec 08, 2011

6:39 AM

Gilead Sciences and World Health Organization Establish New Five-Year Initiative to Prevent Deaths from Visceral Leishmaniasis - Business Wire

Tue, Dec 06, 2011

6:13 PM

Gilead Prices $3.7 Billion of Senior Unsecured Notes - Business Wire

More News for GILD >>

Tags for Gilead Sciences Inc.

Research stocks or mutual funds related to Gilead Sciences Inc. by keywords or tags. Find companies that have a similar focus to GILD. The keywords below have been associated to GILD by either user submission or electronic means.

career opportunities biotechnology company financial debt stock forecasting stock trading operations jobs job search college financial pharmaceuticals research clinical trials liability clinical trials data mount gilead ohio pharmaceutical market online stock quote clinical trial research corporate governance training Commercial Physical And Biological Research (8731) generic pharmaceutical career salaries medical school pharmaceutical investment financial results gilead novel corporate financial annual report msft stock quote pharmaceutical research and development forecasting stock prices annual report financial glossary stock market ticker financial funds financial statement report stock alert japan stock quotes Biological Products pharma marketing pharmaceutical industry marketing traffic alerts research jobs stock market chart corporate governance stock quote pharmaceutical software pharma manufacturing clinical trials volunteers old stock quotes stock alerts pharma license regions financial